Table 2 Clinical and laboratory characteristics among HRV-positive hospitalized children

Age (months) -median (IQR)

21.5 (11.25–37.75)

16 (9–23.5)

0.184^a

Male sex-no. (n, %)

8 (44.4%)

12 (57%)

0.751^b

Clinical symptoms and signs

Fever (n, %)

14 (77.8%)

11 (50.0%)

0.104^b

Cough (n, %)

15 (83.3%)

20 (90.9%)

0.642^b

Nasal obstruction (n, %)

2 (11.1%)

7 (31.8%)

0.149^b

Wheezing (n, %)

6 (33.3%)

8 (36.4%)

1^b

Rhinorrhoea (n, %)

12 (66.7%)

13 (59.1%)

0.747^b

Expectoration (n, %)

6 (33.3%)

16 (72.7%)

0.024^b

Sneeze (n, %)

3 (16.7%)

2 (9.1%)

0.649^b

Heart rate/min-median (IQR)

112 (108.8–123.5)

116 (107–125)

0.916^a

Respiratory rate/min-median (IQR)

26.5 (23.5–30)

28 (25.5–32)

0.206^a

Laboratory tests

Leukocyte (× 10⁹/L)-median (IQR)

11.31(7.48–15.16)

10.86 (7.26–13.84)

0.52^a

Neutrophil percentage (%)-median (IQR)

40.4 (25.65–65.3)

36.3 (27.25–62.65)

0.928^a

Lymphocyte percentage (%)-median (IQR)

47.7 (29.08–64.1)

46.5 (27.9–62.55)

0.815^a

Clinical outcomes and treatment

Bronchopneumonia (%)

12 (66.7%)

14 (63.6%)

1^b

Antibiotic use (%)

5 (27.8%)

6 (27.6%)

1^b